Literature DB >> 28001485

Optimizing assembly and production of native bispecific antibodies by codon de-optimization.

Giovanni Magistrelli1, Yves Poitevin1, Florence Schlosser1, Guillemette Pontini1, Pauline Malinge1, Soheila Josserand1, Marie Corbier1, Nicolas Fischer1.   

Abstract

When production of bispecific antibodies requires the co-expression and assembly of three or four polypeptide chains, low expression of one chain can significantly limit assembly and yield. κλ bodies, fully human bispecific antibodies with native IgG structure, are composed of a common heavy chain and two different light chains, one kappa and one lambda. No engineering is applied to force pairing of the chains, thus both monospecific and bispecific antibodies are secreted in the supernatant. In this context, stoichiometric expression of the two light chains allows for maximal assembly of the bispecific antibody. In this study, we selected a κλ body with suboptimal characteristics due to low kappa chain expression. Codon optimization to increase expression of the kappa chain did not improve bispecific yield. Surprisingly, progressive introduction of non-optimal codons into the sequence of the lambda chain resulted in lowering its expression for an optimal tuning of the relative distribution of monospecific and bispecific antibodies. This codon de-optimization led to doubling of the κλ body yield. These results indicate that assembly of different proteins into a recombinant complex is an interconnected process and that reducing the expression of one polypeptide can actually increase the overall yield.

Entities:  

Keywords:  Affinity chromatography; bispecific antibody; co-expression; codon optimization; protein complex assembly; translation

Mesh:

Substances:

Year:  2017        PMID: 28001485      PMCID: PMC5297534          DOI: 10.1080/19420862.2016.1267088

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  43 in total

1.  Unassembled Ig heavy chains do not cycle from BiP in vivo but require light chains to trigger their release.

Authors:  M Vanhove; Y K Usherwood; L M Hendershot
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

Review 2.  Selection on codon bias.

Authors:  Ruth Hershberg; Dmitri A Petrov
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

3.  Optimization protein productivity of human interleukin-2 through codon usage, gene copy number and intracellular tRNA concentration in CHO cells.

Authors:  Kua-Chun Ou; Chih-Yang Wang; Kuan-Ting Liu; Yi-Ling Chen; Yi-Chen Chen; Ming-Derg Lai; Meng-Chi Yen
Journal:  Biochem Biophys Res Commun       Date:  2014-10-24       Impact factor: 3.575

4.  Enhanced production of α-cyclodextrin glycosyltransferase in Escherichia coli by systematic codon usage optimization.

Authors:  Hua Liu; Jianghua Li; Guocheng Du; Jingwen Zhou; Jian Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2012-08-17       Impact factor: 3.346

5.  Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells.

Authors:  C H Kim; Y Oh; T H Lee
Journal:  Gene       Date:  1997-10-15       Impact factor: 3.688

6.  Codon optimization of xylA gene for recombinant glucose isomerase production in Pichia pastoris and fed-batch feeding strategies to fine-tune bioreactor performance.

Authors:  Özge Ata; Erdem Boy; Hande Güneş; Pınar Çalık
Journal:  Bioprocess Biosyst Eng       Date:  2014-12-10       Impact factor: 3.210

7.  EuGene: maximizing synthetic gene design for heterologous expression.

Authors:  Paulo Gaspar; José Luís Oliveira; Jörg Frommlet; Manuel A S Santos; Gabriela Moura
Journal:  Bioinformatics       Date:  2012-07-30       Impact factor: 6.937

8.  Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.

Authors:  Nicolas Fischer; Greg Elson; Giovanni Magistrelli; Elie Dheilly; Nicolas Fouque; Amélie Laurendon; Franck Gueneau; Ulla Ravn; Jean-François Depoisier; Valery Moine; Sylvain Raimondi; Pauline Malinge; Laura Di Grazia; François Rousseau; Yves Poitevin; Sébastien Calloud; Pierre-Alexis Cayatte; Mathias Alcoz; Guillemette Pontini; Séverine Fagète; Lucile Broyer; Marie Corbier; Delphine Schrag; Gérard Didelot; Nicolas Bosson; Nessie Costes; Laura Cons; Vanessa Buatois; Zoe Johnson; Walter Ferlin; Krzysztof Masternak; Marie Kosco-Vilbois
Journal:  Nat Commun       Date:  2015-02-12       Impact factor: 14.919

9.  Computational codon optimization of synthetic gene for protein expression.

Authors:  Bevan Kai-Sheng Chung; Dong-Yup Lee
Journal:  BMC Syst Biol       Date:  2012-10-20

Review 10.  Advances in recombinant antibody manufacturing.

Authors:  Renate Kunert; David Reinhart
Journal:  Appl Microbiol Biotechnol       Date:  2016-03-03       Impact factor: 4.813

View more
  4 in total

1.  Computational tools for modern vaccine development.

Authors:  Andaleeb Sajid; Yogendra Singh; Pratyoosh Shukla
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

Review 2.  Design and Production of Bispecific Antibodies.

Authors:  Qiong Wang; Yiqun Chen; Jaeyoung Park; Xiao Liu; Yifeng Hu; Tiexin Wang; Kevin McFarland; Michael J Betenbaugh
Journal:  Antibodies (Basel)       Date:  2019-08-02

3.  Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia.

Authors:  Lili Wang; Ilayaraja Muthuramu; Suryanarayan Somanathan; Hong Zhang; Peter Bell; Zhenning He; Hongwei Yu; Yanqing Zhu; Anna P Tretiakova; James M Wilson
Journal:  Mol Ther Methods Clin Dev       Date:  2021-05-05       Impact factor: 6.698

Review 4.  Vaccines for COVID-19.

Authors:  J S Tregoning; E S Brown; H M Cheeseman; K E Flight; S L Higham; N-M Lemm; B F Pierce; D C Stirling; Z Wang; K M Pollock
Journal:  Clin Exp Immunol       Date:  2020-10-18       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.